Bioceltix S.A. (WSE:BCX)
106.60
+3.60 (3.50%)
Jun 6, 2025, 5:02 PM CET
Bioceltix Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 32.57 | 33.63 | 9.31 | 4.12 | 6.05 |
Cash & Short-Term Investments | 32.57 | 33.63 | 9.31 | 4.12 | 6.05 |
Cash Growth | 365.53% | 261.24% | 125.98% | -31.96% | - |
Accounts Receivable | - | 0 | 0 | 0 | - |
Other Receivables | 3.68 | 4.98 | 1.88 | 0.23 | 0.44 |
Receivables | 3.68 | 4.98 | 1.88 | 0.23 | 0.44 |
Inventory | 0.01 | 0.01 | 0.01 | - | - |
Prepaid Expenses | - | 0.02 | 0.01 | 0.01 | 0.01 |
Other Current Assets | - | 0.77 | 0 | 1.67 | 0.01 |
Total Current Assets | 36.26 | 39.42 | 11.21 | 6.02 | 6.51 |
Property, Plant & Equipment | 2.63 | 2.37 | 1.48 | 1.46 | 1.53 |
Long-Term Deferred Tax Assets | 0.04 | 0.03 | 0.04 | 0.03 | 0.02 |
Other Long-Term Assets | 0.38 | 0.03 | - | 0.14 | 0.14 |
Total Assets | 39.31 | 41.85 | 12.74 | 7.65 | 8.2 |
Accounts Payable | - | 1.49 | 1.21 | 0.96 | 0.29 |
Accrued Expenses | 0.28 | 0.56 | 0.44 | 0.34 | 0.19 |
Current Portion of Leases | - | 0.67 | 0.1 | 0.12 | 0.38 |
Current Income Taxes Payable | - | 0.46 | 0.36 | 0.27 | 0.12 |
Current Unearned Revenue | - | 0.01 | 0.03 | 0.56 | 0.93 |
Total Current Liabilities | 4.41 | 3.2 | 2.14 | 2.25 | 1.91 |
Long-Term Leases | - | 0.15 | 0.08 | 0.18 | 0.15 |
Long-Term Unearned Revenue | - | - | - | 0.03 | 0.06 |
Long-Term Deferred Tax Liabilities | 0.09 | 0.07 | 0.04 | 0.04 | 0.07 |
Total Liabilities | 4.69 | 3.44 | 2.27 | 2.5 | 2.2 |
Common Stock | 0.49 | 0.49 | 0.41 | 0.34 | 0.33 |
Additional Paid-In Capital | 52.82 | 52.82 | 23.8 | 14.44 | 15.14 |
Retained Earnings | -18.69 | -14.9 | -13.74 | -13.99 | -9.47 |
Comprehensive Income & Other | - | - | - | 4.36 | - |
Shareholders' Equity | 34.62 | 38.42 | 10.47 | 5.15 | 6 |
Total Liabilities & Equity | 39.31 | 41.85 | 12.74 | 7.65 | 8.2 |
Total Debt | - | 0.82 | 0.18 | 0.29 | 0.53 |
Net Cash (Debt) | 32.57 | 32.81 | 9.14 | 3.83 | 5.52 |
Net Cash Growth | 384.26% | 259.15% | 138.76% | -30.74% | - |
Net Cash Per Share | 6.88 | 7.23 | 2.33 | 1.15 | 1.75 |
Filing Date Shares Outstanding | 4.92 | 4.92 | 4.13 | 3.98 | 3.29 |
Total Common Shares Outstanding | 4.92 | 4.92 | 4.13 | 3.43 | 3.29 |
Working Capital | 31.86 | 36.23 | 9.07 | 3.78 | 4.61 |
Book Value Per Share | 7.03 | 7.80 | 2.53 | 1.50 | 1.82 |
Tangible Book Value | 34.62 | 38.42 | 10.47 | 5.15 | 6 |
Tangible Book Value Per Share | 7.03 | 7.80 | 2.53 | 1.50 | 1.82 |
Buildings | - | 0.33 | 0.33 | 0.33 | 0.33 |
Machinery | - | 0.3 | 0.27 | 0.24 | 0.25 |
Construction In Progress | - | 0.1 | - | - | - |
Updated Nov 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.